NOMO2 (NM_173614) Human Mass Spec Standard

CAT#: PH323358

NOMO2 MS Standard C13 and N15-labeled recombinant protein (NP_775885)



  View other "NOMO2" proteins (3)

Need it in bulk or customized?
Get a free quote

CNY 14250.00


货期*
5周

规格
    • 10 ug

Product images

推荐一起购买 (2)
NOMO2 Rabbit polyclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00


Transient overexpression lysate of NODAL modulator 2 (NOMO2), transcript variant 1
    • 100 ug

CNY 4840.00

Specifications

Product Data
Description NOMO2 MS Standard C13 and N15-labeled recombinant protein (NP_775885)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC223358
Predicted MW 134 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_775885
RefSeq Size 4317
RefSeq ORF 3666
Synonyms Nomo; PM5
Locus ID 283820
Cytogenetics 16p12.3
Summary This gene encodes a protein originally thought to be related to the collagenase gene family. This gene is one of three highly similar genes in a region of duplication located on the p arm of chromosome 16. These three genes encode closely related proteins that may have the same function. The protein encoded by one of these genes has been identified as part of a protein complex that participates in the Nodal signaling pathway during vertebrate development. Mutations in ABCC6, which is located nearby, rather than mutations in this gene are associated with pseudoxanthoma elasticum (PXE). Two transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...